- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Iron deficiency anaemia
- Meeting Date: August 2019
- Public Summary Document (PSD) August 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) August 2019 PBAC Meeting - (Word 181KB)
Ferric derisomaltose – August 2019
FERRIC DERISOMALTOSE Injection 1000 mg (iron) in 10 mL, Injection 500 mg (iron) in 5 mL, Monofer®, Pfizer Australia Pty Ltd.
Last updated
31 January 2020